Cite
HARVARD Citation
Schey, S. et al. (n.d.). Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial. British journal of haematology. pp. 336-348. [Online].